Javier Velasco-Montes, Itziar Oriñuela-González, Ainhoa Z Sanjuán-López
Hospital Santiago Apóstol, Servicio de Medicina Interna, Vitoria-Gasteiz, España. javier_velasco_montes@hotmail.com
Actas españolas de psiquiatría 2012 Mar-AprQuetiapine is one of the drugs used most in current Psychiatry due to its therapeutic efficiency and clinical safety. We report the case of a 26-year-old male patient with severe mental retardation due to Y-chromosome partial deletion who initiated treatment with quetiapine for the control of his aggressiveness, and who developed severe rhabdomyolysis two weeks later. In spite of the confirmed clinical safety of quetiapine, doctors must monitor the appearance of rare but serious adverse effects as that presented in this clinical case.
Javier Velasco-Montes, Itziar Oriñuela-González, Ainhoa Z Sanjuán-López. Rhabdomyolysis secondary to quetiapine. Actas españolas de psiquiatría. 2012 Mar-Apr;40(2):97-9
PMID: 22508075
View Full Text